REAL-WORLD PERSISTENCE WITH FREMANEZUMAB VERSUS ERENUMAB AMONG MIGRAINE PATIENTS.
Autor: | Bermejo, M. Gómez, Martín-Zaragoza, L., Ferrández, J. Sánchez-Rubio, Garzo-Bleda, C., Maraver-Villar, A., Herranz-Muñoz, N., Onteniente-González, A., Rubio-Ruiz, L., MartínÁvila, G., Terrero-Carpio, R., Molina-Garcia, T. |
---|---|
Zdroj: | European Journal of Hospital Pharmacy; 2024 Supplement, Vol. 31, pA95-A95, 1/2p |
Databáze: | Supplemental Index |
Externí odkaz: |